# ENCO-BRAF (NCT04526782)

> ENCOrafenib With Binimetinib in bRAF NSCLC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04526782
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Intergroupe Francophone de Cancerologie Thoracique
- Conditions: Non Small Cell Lung Cancer; BRAF V600E
- Interventions: Encorafenib 75 MG; Binimetinib 15 MG
- Enrollment: 119
- Primary outcome: Objective response rate

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 12
- Podcasts: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=enco-braf-nct04526782

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04526782", "email": "<work email>"}; the inbox owner confirms by the emailed link.